Published in Fertil Steril on August 29, 2013
Effects of Salpingectomy During Laparoscopic Hysterectomy on Ovarian Function | NCT01578759
The postreproductive salpingectomy. Fertil Steril (2014) 1.10
Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecol Oncol (2014) 0.94
Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update. J Obstet Gynaecol Res (2014) 0.92
Major clinical research advances in gynecologic cancer in 2014. J Gynecol Oncol (2015) 0.90
Opportunistic salpingectomy for ovarian cancer prevention. Gynecol Oncol Res Pract (2015) 0.84
Salpingectomy as a means to reduce ovarian cancer risk. Cancer Prev Res (Phila) (2015) 0.80
Incidental (Prophylactic) Salpingectomy at Benign Gynecologic Surgery and Cesarean Section: a Survey of Practice in Austria. Geburtshilfe Frauenheilkd (2016) 0.79
Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review. Reprod Biol Endocrinol (2014) 0.78
Ovarian cancer risk reduction through opportunistic salpingectomy. J Gynecol Oncol (2015) 0.76
Prophylactic salpingectomy in premenopausal women at low risk for ovarian cancer: risk-reducing or risky? Fertil Steril (2013) 0.75
Salpingectomy before assisted reproductive technologies: a systematic literature review. J Ovarian Res (2016) 0.75
Should national societies recommend opportunistic salpingectomy? J Gynecol Oncol (2017) 0.75
Should Fallopian Tubes Be Removed During Hysterectomy Procedures? - A Statement by AGO Ovar. Geburtshilfe Frauenheilkd (2015) 0.75
Ovarian function and ovarian blood supply following premenopausal abdominal hysterectomy. Prz Menopauzalny (2015) 0.75
Reply of the authors. Fertil Steril (2014) 0.75
Risk-reducing salpingectomy: Let us be opportunistic. Cancer (2017) 0.75
Evaluation of ovarian function after hysterectomy with or without salpingectomy: A feasible study. J Res Med Sci (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol (2011) 5.53
Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA (2013) 4.67
Hysterectomy rates in the United States, 2003. Obstet Gynecol (2007) 4.57
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA (2006) 4.09
The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer (2010) 4.06
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol (2010) 2.10
Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol (2013) 1.92
A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause (2009) 1.90
Predicting age at menopause from serum antimüllerian hormone concentration. Menopause (2011) 1.85
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril (2004) 1.81
Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006. Obstet Gynecol (2010) 1.46
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol (2003) 1.43
Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels. Fertil Steril (2009) 1.31
The post-reproductive Fallopian tube: better removed? Hum Reprod (2011) 1.31
The role of the fallopian tube in ovarian cancer. Clin Adv Hematol Oncol (2012) 1.23
Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab (2013) 1.09
Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer. Int J Gynecol Cancer (2013) 1.06
Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res (2007) 1.04
Serum antimüllerian hormone in healthy premenopausal women. Fertil Steril (2011) 0.97
Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal. Fertil Steril (2011) 0.91
Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol (2003) 1.68
Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Am J Obstet Gynecol (2005) 1.49
Decreased incidence of vaginal cuff dehiscence after laparoscopic closure with bidirectional barbed suture. J Minim Invasive Gynecol (2011) 1.30
The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years. Menopause (2010) 1.19
A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. J Clin Endocrinol Metab (2010) 1.16
Identification of diagnostic subtypes of chronic pelvic pain and how subtypes differ in health status and trauma history. Am J Obstet Gynecol (2006) 0.98
Prevalence and characteristics of irritable bowel syndrome among women with chronic pelvic pain. Obstet Gynecol (2004) 0.98
The utility of menstrual cycle length as an indicator of cumulative hormonal exposure. J Clin Endocrinol Metab (2012) 0.97
Preoperative ultrasound to predict infraumbilical adhesions: a study of diagnostic accuracy. Am J Obstet Gynecol (2005) 0.95
Cholesterol, endocrine and metabolic disturbances in sporadic anovulatory women with regular menstruation. Hum Reprod (2010) 0.93
Mechanical bowel preparation before laparoscopic hysterectomy: a randomized controlled trial. Obstet Gynecol (2014) 0.92
Effect of extreme obesity on outcomes in laparoscopic hysterectomy. J Minim Invasive Gynecol (2012) 0.91
Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol (2003) 0.88
Quality of life and sexual function after hysterectomy in women with preoperative pain and depression. Obstet Gynecol (2004) 0.88
Refining retinoic acid stimulation for osteogenic differentiation of murine adipose-derived adult stromal cells. Tissue Eng (2007) 0.88
Documenting the current definitions of chronic pelvic pain: implications for research. Obstet Gynecol (2004) 0.87
Chronic pelvic pain. Obstet Gynecol (2014) 0.86
Maternal antimullerian hormone levels do not predict fetal aneuploidy. J Assist Reprod Genet (2010) 0.86
Management of a persistent adnexal mass in pregnancy: what is the ideal surgical approach? J Minim Invasive Gynecol (2011) 0.84
Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive. Fertil Steril (2013) 0.83
Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability. Am J Epidemiol (2012) 0.83
Pelvic congestion syndrome-associated pelvic pain: a systematic review of diagnosis and management. Obstet Gynecol Surv (2010) 0.83
Anti-Müllerian hormone and lifestyle, reproductive, and environmental factors among women in rural South Africa. Epidemiology (2015) 0.83
Obesity: physiologic changes and challenges during laparoscopy. Am J Obstet Gynecol (2004) 0.83
Musculoskeletal causes of chronic pelvic pain: a systematic review of diagnosis: part I. Obstet Gynecol Surv (2005) 0.82
Updates in uterine fibroid tissue extraction. Curr Opin Obstet Gynecol (2016) 0.81
Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause. Am J Obstet Gynecol (2004) 0.81
Prevalence of pelvic musculoskeletal disorders in a female chronic pelvic pain clinic. J Reprod Med (2006) 0.81
Etiology of azoospermia in a large nonreferral inner-city population. Fertil Steril (2006) 0.80
The anatomy and neurophysiology of pelvic pain. J Minim Invasive Gynecol (2006) 0.79
Long-term outcomes after surgical and nonsurgical management of chronic pelvic pain: one year after evaluation in a pelvic pain specialty clinic. Am J Obstet Gynecol (2006) 0.79
Musculoskeletal causes of chronic pelvic pain: a systematic review of existing therapies: part II. Obstet Gynecol Surv (2005) 0.79
Association between serum 25-hydroxyvitamin D and ovarian reserve in premenopausal women. Menopause (2015) 0.78
Trainee participation in an annual research day is associated with future publications. Teach Learn Med (2011) 0.78
Predictors and implications of estradiol rise after gonadotropin-releasing hormone antagonist initiation during in vitro fertilization cycles. J Reprod Med (2009) 0.78
The role of laparoscopy in the diagnosis and treatment of conditions associated with chronic pelvic pain. Obstet Gynecol Clin North Am (2004) 0.77
Open-label trial of lamotrigine focusing on efficacy in vulvodynia. J Reprod Med (2009) 0.75
Conveying and discussing uncertainty- looking in both directions. Fertil Steril (2004) 0.75
Periconceptional changes in thyroid function: a longitudinal study. Reprod Biol Endocrinol (2012) 0.75
Anti-müllerian hormone (AMH) and repetitive oocyte donation. Fertil Steril (2010) 0.75
Pelvic pain phenotyping: the key to progress. Obstet Gynecol (2009) 0.75
Severe ovarian hyperstimulation syndrome after letrozole-gonadotropin stimulation: a case report. J Assist Reprod Genet (2011) 0.75
The role of simulation and warm-up in minimally invasive gynecologic surgery. Curr Opin Obstet Gynecol (2017) 0.75
Vaginal apex resection: a treatment option for vaginal apex pain. Obstet Gynecol (2004) 0.75
Effect of vaginal lubricants on natural fertility. Curr Opin Obstet Gynecol (2014) 0.75
Efficient use of early obstetric sonography in the emergency department setting. J Ultrasound Med (2012) 0.75
Management considerations for patients with uterine fibroids and concurrent venous thromboembolism. Curr Opin Obstet Gynecol (2016) 0.75